Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 115

1.

The Health and economic effects of light rail lines: design, methods, and protocol for a natural experiment.

Frank LD, Kuntz JL, Chapman JE, Fox EH, Dickerson JF, Meenan RT, Saelens BE, Young DR, Boone-Heinonen J, Fortmann SP.

BMC Public Health. 2019 Feb 15;19(1):200. doi: 10.1186/s12889-019-6518-6.

2.

Development and Assessment of Risk Scores for Carbapenem and Extensive β-Lactam Resistance Among Adult Hospitalized Patients With Pseudomonas aeruginosa Infection.

Tartof SY, Kuntz JL, Chen LH, Wei R, Puzniak L, Tian Y, Im TM, Takhar HS, Merchant S, Lodise T.

JAMA Netw Open. 2018 Oct 5;1(6):e183927. doi: 10.1001/jamanetworkopen.2018.3927.

3.

Patient Education and Pharmacist Consultation Influence on Nonbenzodiazepine Sedative Medication Deprescribing Success for Older Adults.

Kuntz JL, Kouch L, Christian D, Hu W, Peterson PL.

Perm J. 2019;23:18-161. doi: 10.7812/TPP/18-161.

4.

Development of an Intervention to Reduce Pain and Prevent Syncope Related to Adolescent Vaccination.

Kuntz JL, Firemark A, Schneider J, Henninger M, Bok K, Naleway A.

Perm J. 2019;23:17-136. doi: 10.7812/TPP/17-136.

5.

A randomized, pragmatic, pharmacist-led intervention reduced opioids following orthopedic surgery.

Smith DH, Kuntz JL, DeBar LL, Mesa J, Yang X, Schneider J, Petrik A, Reese K, Thorsness LA, Boardman D, Johnson ES.

Am J Manag Care. 2018 Nov;24(11):515-521.

6.

Feasibility of a pilot intervention to reduce pain and syncope during adolescent vaccination.

Henninger ML, Kuntz JL, Firemark AJ, Varga AM, Bok K, Naleway AL.

Vaccine. 2018 Jun 22;36(27):3937-3942. doi: 10.1016/j.vaccine.2018.05.070. Epub 2018 May 24.

PMID:
29805090
7.

Evaluation of the US Food and Drug Administration sentinel analysis tools in confirming previously observed drug-outcome associations: The case of clindamycin and Clostridium difficile infection.

Carnahan RM, Kuntz JL, Wang SV, Fuller C, Gagne JJ, Leonard CE, Hennessy S, Meyer T, Archdeacon P, Chen CY, Panozzo CA, Toh S, Katcoff H, Woodworth T, Iyer A, Axtman S, Chrischilles EA.

Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):731-739. doi: 10.1002/pds.4420. Epub 2018 Mar 13.

PMID:
29532543
8.

Bisphosphonate Drug Holiday and Fracture Risk: A Population-Based Cohort Study.

Adams AL, Adams JL, Raebel MA, Tang BT, Kuntz JL, Vijayadeva V, McGlynn EA, Gozansky WS.

J Bone Miner Res. 2018 Jul;33(7):1252-1259. doi: 10.1002/jbmr.3420. Epub 2018 May 24.

9.

Utilization of Health Services Among Adults With Recurrent Clostridium difficile Infection: A 12-Year Population-Based Study.

Kuntz JL, Baker JM, Kipnis P, Li SX, Liu V, Xie Y, Marcella S, Escobar GJ.

Infect Control Hosp Epidemiol. 2017 Jan;38(1):45-52. doi: 10.1017/ice.2016.232. Epub 2016 Oct 20.

10.

Predicting the Risk of Clostridium difficile Infection upon Admission: A Score to Identify Patients for Antimicrobial Stewardship Efforts.

Kuntz JL, Smith DH, Petrik AF, Yang X, Thorp ML, Barton T, Barton K, Labreche M, Spindel SJ, Johnson ES.

Perm J. 2016 Winter;20(1):20-5. doi: 10.7812/TPP/15-049.

11.

Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies.

Hansen C, Andrade SE, Freiman H, Dublin S, Haffenreffer K, Cooper WO, Cheetham TC, Toh S, Li DK, Raebel MA, Kuntz JL, Perrin N, Rosales AG, Carter S, Pawloski PA, Maloney EM, Graham DJ, Sahin L, Scott PE, Yap J, Davis R.

Pharmacoepidemiol Drug Saf. 2016 Feb;25(2):170-8. doi: 10.1002/pds.3919. Epub 2015 Nov 24.

12.

Clostridium difficile Infection Among Veterans Health Administration Patients.

Young-Xu Y, Kuntz JL, Gerding DN, Neily J, Mills P, Dubberke ER, Olsen MA, Kelly CP, Mahé C.

Infect Control Hosp Epidemiol. 2015 Sep;36(9):1038-45. doi: 10.1017/ice.2015.138. Epub 2015 Jun 5.

PMID:
26047207
13.

Identification of Stevens-Johnson syndrome and toxic epidermal necrolysis in electronic health record databases.

Davis RL, Gallagher MA, Asgari MM, Eide MJ, Margolis DJ, Macy E, Burmester JK, Selvam N, Boscarino JA, Cromwell LF, Feigelson HS, Kuntz JL, Pawloski PA, Penfold RB, Raebel MA, Sridhar G, Wu A, La Grenade LA, Pacanowski MA, Pinheiro SP.

Pharmacoepidemiol Drug Saf. 2015 Jul;24(7):684-92. doi: 10.1002/pds.3778. Epub 2015 Apr 24.

PMID:
25914229
14.

Predicting the risk of Clostridium difficile infection following an outpatient visit: development and external validation of a pragmatic, prognostic risk score.

Kuntz JL, Johnson ES, Raebel MA, Platt RW, Petrik AF, Yang X, Thorp ML, Spindel SJ, Neil N, Smith DH.

Clin Microbiol Infect. 2015 Mar;21(3):256-62. doi: 10.1016/j.cmi.2014.11.001. Epub 2014 Nov 11.

15.

The importance of considering different healthcare settings when estimating the burden of Clostridium difficile.

Kuntz JL, Polgreen PM.

Clin Infect Dis. 2015 Mar 15;60(6):831-6. doi: 10.1093/cid/ciu955. Epub 2014 Dec 4.

PMID:
25477426
16.

Patient-centered interventions to improve medication management and adherence: a qualitative review of research findings.

Kuntz JL, Safford MM, Singh JA, Phansalkar S, Slight SP, Her QL, Lapointe NA, Mathews R, O'Brien E, Brinkman WB, Hommel K, Farmer KC, Klinger E, Maniam N, Sobko HJ, Bailey SC, Cho I, Rumptz MH, Vandermeer ML, Hornbrook MC.

Patient Educ Couns. 2014 Dec;97(3):310-26. doi: 10.1016/j.pec.2014.08.021. Epub 2014 Sep 16. Review.

17.

Epidemiology and healthcare costs of incident Clostridium difficile infections identified in the outpatient healthcare setting.

Kuntz JL, Johnson ES, Raebel MA, Petrik AF, Yang X, Thorp ML, Spindel SJ, Neil N, Smith DH.

Infect Control Hosp Epidemiol. 2012 Oct;33(10):1031-8. doi: 10.1086/667733. Epub 2012 Aug 23.

PMID:
22961023
18.

Clostridium difficile infection, Colorado and the northwestern United States, 2007.

Kuntz JL, Johnson ES, Raebel MA, Petrik AF, Yang X, Thorp ML, Spindel SJ, Neil N, Smith DH.

Emerg Infect Dis. 2012 Jun;18(6):960-2. doi: 10.3201/eid1806.111528.

19.

Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study.

Kuntz JL, Chrischilles EA, Pendergast JF, Herwaldt LA, Polgreen PM.

BMC Infect Dis. 2011 Jul 15;11:194. doi: 10.1186/1471-2334-11-194.

20.

Using oral vancomycin prescriptions as a proxy measure for Clostridium difficile infections: a spatial and time series analysis.

Polgreen PM, Yang M, Kuntz JL, Laxminarayan R, Cavanaugh JE.

Infect Control Hosp Epidemiol. 2011 Jul;32(7):723-6. doi: 10.1086/660858.

Supplemental Content

Loading ...
Support Center